Average Co-Inventor Count = 8.59
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Merck + Co., Inc. (1 from 4,770 patents)
3. Msd R&d (china) Co., Ltd. (1 from 10 patents)
4. Msd R&d Co., Ltd. (0 patent)
14 patents:
1. 10647727 - Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
2. 10357481 - Substituted triazolo bicyclic compounds as PDE2 inhibitors
3. 10138255 - Piperazine derivatives as HIV protease inhibitors
4. 9840478 - Piperazine derivatives as HIV protease inhibitors
5. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
6. 8933102 - Pyrrolidine derived β3 adrenergic receptor agonists
7. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
8. 8618144 - Pyrrolidine-derived beta 3 adrenergic receptor agonists
9. 8604038 - Pyrrolidine derived beta 3 adrenergic receptor agonists
10. 8501786 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
11. 8399480 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
12. 8354403 - Pyrrolidine derived beta 3 adrenergic receptor agonists
13. 8247415 - Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
14. 7084156 - 2-Aminoquinoline compounds